![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|18|6|547-554
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.18, Iss.6, 2018-11, pp. : 547-554
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome
Current Pharmaceutical Design, Vol. 13, Iss. 21, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Non-alcoholic fatty liver disease: a massive problem
Clinical Medicine, Vol. 11, Iss. 2, 2011-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)